Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page
- ChecktodayChange DetectedRecruitment status has been updated to closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The removal of the old 'Intervention / Treatment' heading and the update to the site revision banner (v3.6.0) reflect a reorganization and version update.SummaryDifference0.2%

- Check7 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects an update to the page’s versioning rather than changes to the study content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the site; the study details and navigation remain unchanged.SummaryDifference0.0%

- Check43 days agoChange DetectedThe Malmö, Sweden entry replaces Malmo, Sweden, 211 46 to reflect the proper Swedish spelling in the study locations.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s displayed software/version revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.